Editorial [Hot Topic: Kidney Cancer: State of the Art in 2011 (Guest Editor: Ulka Vaishampayan)]
Journal:
Current Clinical Pharmacology
Volume:
6
Page:
143-143
Author(s):
Ulka Vaishampayan
Adjuvant and Neoadjuvant Therapy in Renal Cell Carcinoma
Journal:
Current Clinical Pharmacology
Volume:
6
Page:
144-150
Author(s):
Michel Choueiri, Nizar Tannir and Eric Jonasch
Immunotherapy of Kidney Cancer
Journal:
Current Clinical Pharmacology
Volume:
6
Page:
151-163
Author(s):
Petros D. Grivas and Bruce G. Redman
VEGF Inhibitors in Metastatic Renal Cell Carcinoma: Current Therapies and Future Perspectives
Journal:
Current Clinical Pharmacology
Volume:
6
Page:
164-168
Author(s):
Toni K. Choueiri
Toxicities of Targeted Agents in Advanced Renal Cell Carcinoma
Journal:
Current Clinical Pharmacology
Volume:
6
Page:
181-188
Author(s):
Priti Patel and Sandy Srinivas
Emerging Targeted Therapies in Metastatic Renal Cell Carcinoma
Journal:
Current Clinical Pharmacology
Volume:
6
Page:
189-198
Author(s):
Marc R. Matrana, Bradley Atkinson, Eric Jonasch and Nizar M. Tannir
Looking Beyond Inhibition of VEGF/mTOR: Emerging Targets for Renal Cell Carcinoma Drug Development
Journal:
Current Clinical Pharmacology
Volume:
6
Page:
199-206
Author(s):
Neal Rasmussen and W. Kimryn Rathmell
Oxidative Stress and its Clinical Consequences: Relationship between Diabetes and Cancer
Journal:
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume:
10
Page:
286-298
Author(s):
Victor M. Victor, Antonio Hernandez-Mijares and Milagros Rocha
Radiolabeled Oligonucleotides for Antisense Imaging
Journal:
Current Organic Synthesis
Volume:
8
Page:
604-614
Author(s):
Arun K. Iyer and Jiang He
From Data Processing to Multivariate Validation - Essential Steps in Extracting Interpretable Information from Metabolomics Data
Journal:
Current Pharmaceutical Biotechnology
Volume:
12
Page:
996-1004
Author(s):
Mattias Eliasson, Stefan Rannar and Johan Trygg